Cisplatin-functionalized three-dimensional magnetic SBA-16 for treating breast cancer cells (MCF-7). Issue 1 (4th December 2019)
- Record Type:
- Journal Article
- Title:
- Cisplatin-functionalized three-dimensional magnetic SBA-16 for treating breast cancer cells (MCF-7). Issue 1 (4th December 2019)
- Main Title:
- Cisplatin-functionalized three-dimensional magnetic SBA-16 for treating breast cancer cells (MCF-7)
- Authors:
- Alomari, Munther
Jermy, B. Rabindran
Ravinayagam, Vijaya
Akhtar, Sultan
Almofty, Sarah Ameen
Rehman, Suriya
Bahmdan, Hiba
AbdulAzeez, Sayed
Borgio, J. Francis - Abstract:
- Abstract: The engineering of multifunctional therapeutics in an integrated single platform is demonstrated using three-dimensional SBA-16 (S-16). 10 wt% iron oxide nanoparticles (Fe) were loaded into the cage type of cubic pores through enforced adsorption technique. Fe/S-16 is then functionalized with amine-based silane (A), polyacrylic acid (P) and cisplatin (Cp). The physicochemical textural analysis showed the formation of nano metal oxide distributions at pore walls of S-16 with magnetization of 2.39 emu/g. S-16 based nanoformulations showed high percentage of Cp adsorption (90%) and percentage cumulative release (60%). in vitro study of Fe/S-16-A-Cp showed high toxicity against breast cancer cell line MCF-7 and normal cell line Human foreskin fibroblast (HFF-1) compared to Fe/S-16 indicating cisplatin profusion inside the cells than free cisplatin. While skin fibroblast seems to be resistant to Fe/S-16-AP-Cp with very high LC50 in compare to MCF-7. This indicates the unrelease of cisplatin in skin fibroblast after Fe/S-16-AP-Cp treatment due to effective encapsulation inside the cubic pores and core blockage due to pH-sensitive polyacrylic acid. Also, these treatments resulted in morphological changes in the cells such as DNA condensation and nuclear fragmentation.
- Is Part Of:
- Artificial cells, nanomedicine, and biotechnology. Volume 47:Issue 1(2019)
- Journal:
- Artificial cells, nanomedicine, and biotechnology
- Issue:
- Volume 47:Issue 1(2019)
- Issue Display:
- Volume 47, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 47
- Issue:
- 1
- Issue Sort Value:
- 2019-0047-0001-0000
- Page Start:
- 3079
- Page End:
- 3086
- Publication Date:
- 2019-12-04
- Subjects:
- SPIONs -- cisplatin -- SBA-16 -- polyacrylic acid -- nanotherapeutics -- cancer therapy -- MCF-7 -- HFF-1 -- TEM
Artificial cells -- Periodicals
Nanotechnology -- Periodicals
Blood substitutes -- Periodicals
Tissue engineering -- Periodicals
Molecules -- Periodicals
Biotechnology -- Periodicals
615.39 - Journal URLs:
- http://informahealthcare.com/loi/abb?open=2012#id_2012 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/21691401.2019.1645155 ↗
- Languages:
- English
- ISSNs:
- 2169-1401
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25786.xml